Regulation of heme oxygenase-1 induction during recurrent insulin induced hypoglycemia

  • Authors

    • Syed Quadri ULM College of Pharmacy
    • Priyanka Prathipati ULM College of Pharmacy
    • Debra Jackson ULM College of Arts, Education, and Sceince
    • Keith Jackson ULM College of Pharmacy
    2014-06-23
    https://doi.org/10.14419/ijm.v2i2.2902

  • Abstract

    Background: Recurrent insulin induced hypoglycemia (RIIH) is an unavoidable risk of conventional therapeutic management of insulin dependent diabetes mellitus and is a primary cause of impaired glucose counter regulation. Circulating angiotensin II (AngII) has been reported to be elevated in diabetic models, and is linked to the promotion of hypertension.

    Objective: The current study was performed to evaluate the hypothesis that chronic insulin injections and/or hypoglycemia promotes hypertension via an increase in AngII, which increases endogenous carbon monoxide (CO) through an induction in heme oxygenase (HO-1).

    Methods: Male Sprague Dawley rats (200 – 250g) were treated for 2 weeks with daily injections of 7U/kg insulin or diluent. On the 14th day, surgery was performed and rats were administered various doses of captopril (2mg/kg, 8mg/kg, and 12mg/kg) or vehicle. Following the dose evaluation, subsets of previously treated animals were treated with vehicle, DALA (80µg/kg), Captopril (12mg/kg) or a combination of DALA (80µg/kg) + CAP (12mg/kg).

    Results: A dose dependent decrease in blood pressure was observed during captopril treatment in RIIH hypertensive rats. However, there was no change in urine output among the treatment groups. Captopril and DALA+CAP treatments produced a reduction in blood pressure as compared to animals treated with DALA alone. Carboxyhemoglobin and AngII concentrations were also reduced in animals treated with captopril and DALA+CAP. In addition, HO-1 protein levels in heart and kidney were reduced when compared to DALA treated animals.

    Conclusion: These results demonstrate that RIIH promotes an increase in circulating AngII and hypertension via an induction in HO-1, which significantly increases endogenous CO levels.

     

    Keywords: Angiotensin II, Carbon Monoxide, Heme Oxygenase, Recurring Insulin-Induced Hypoglycemia (RIIH).

  • References

    1. Briscoe VJ, Tate DB & Davis SN (2007) Type 1 diabetes exercise and hypoglycemia. Appl Physiol Nutr Metab 32, 573-582.
    2. Hoffman RP (2007) Sympathetic mechanism of hypoglycemic counter regulation. Curr Diabetes Rev 3, 185-193.
    3. Fisher BM, Gillen G, Dargie HJ, Inglis GC & Frier BM (1987) The effects of insulin-induced hypoglycaemia on cardiovascular function in normal man: studies using radionuclide ventriculography. Diabetologia 30, 841-845.
    4. Fisher BM, Gillen G, Hepburn DA, Dargie HJ & Frier BM (1990) Cardiac responses to acute insulin-induced hypoglycemia in humans. Am J Physiol 258, H1775-9.
    5. Das Evcimen N & King GL (2007) The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55, 498-510.
    6. Fukami K, Yamagishi S, Ueda S & Okuda S (2007) Novel therapeutic targets for diabetic nephropathy. Endocr Metab Immune Disord Drug Targets 7, 83-92.
    7. Eadington DW, Frier BM & Swainson CP (1994) Renal tubular responses to low-dose infusion of angiotensin II in type 1 diabetes mellitus; relation to chronic glycaemic control. Nephrol Dial Transplant 9, 1264-1270.
    8. Harrison-Bernard LM, Imig JD & Carmines PK (2002) Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res 3, 97-108.
    9. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW & Miller JA (2006) Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes J Am Soc Nephrol 17, 1703-9.
    10. Brands MW & Fitzgerald SM (2002) Blood pressure control early in diabetes: a balance between angiotensin II and nitric oxide. Clin Exp Pharmacol Physiol 29, 127-31.
    11. Bank AJ, Kelly AS, Thelen AM, Kaiser DR & Gonzalez-Campoy JM (2007) Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens 20, 777-83.
    12. Johnson RA, Lavesa M, Askari B, Abraham NG & Nasjletti A (1995) A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25, 166-9.
    13. Johnson FK, Terran FJ, Prieto-Carrasquero M & Johnson RA (2002) Vascular effects of an inhibitor of heme oxygenase are enhanced in the absence of nitric oxide. Am J Hypertens 15, 1074-1080.
    14. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37, 517-54.
    15. Jackson KE, Jackson DW, Quadri S, Reitzell MJ & Navar LG (2011) Inhibition of heme oxygenase augments tubular sodium reabsorption. Am J Physiol Renal Physiol 300, F941-F946.
    16. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR & Ohno M (2000) Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection. Hypertension 35, 800-6.
    17. Haugen EN, Croatt AJ & Nath KA (2000) Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58, 144-52.
    18. Quan S, Yang L, Shnouda S, Schwartzman ML, Nasjletti A, Goodman AI & Abraham NG (2004 ) Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int 65, 1628-39.
    19. Hu Y, Ma N, Yang M & Semba R (1998) Expression and distribution of heme oxygenase-2 mRNA and protein in rat kidney. J Histochem Cytochem 46, 249-56.
    20. Grundemar L, Johansson MB, Ekelund M & Högestätt ED (1995) Haem oxygenase activity in blood vessel homogenates as measured by carbon monoxide production. Acta Physiol Scand 153, 203-4.
    21. Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, Green CJ & Motterlini R (1998) Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 125, 1437-44.
    22. Ferrándiz ML & Devesa I (2008) Inducers of heme oxygenase-1. Curr Pharm Des 14, 473-86.
    23. Johnson FK, Durante W, Peyton KJ & Johnson RA (2004) Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles. Am J Physiol Heart Circ Physiol 286, H1681-7.
    24. Ishizaka N, Aizawa T, Mori I, Taguchi J, Yazaki Y, Nagai R & Ohno M (2000) Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol 279, H672-8.
    25. Quadri S, Prathipati P, Jackson DW & Jackson KE (2014) Hemodynamic consequences of recurrent insulin-induced hypoglycaemia. Clin Exp Pharmacol Physiol 41, 81-8.
    26. Botros FT, Olszanecki R, Prieto-Carrasquero MC, Goodman AL, Navar LG & Abraham NG (2007) Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol 53, 51-60.
    27. Freidja ML, Toutain B, Caillon A, Desquiret V, Lambert D, Loufrani L, Procaccio V & Henrion D (2011) Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide. Hypertension 58, 225-31.
    28. Li P, Jiang H, Yang L, Quan S, Dinocca S, Rodriguez F, Abraham NG & Nasjletti A (2004) Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation. Am J Physiol Renal Physiol 287, F914-20.
    29. Jadhav A, Torlakovic E & Ndisang JF (2008) Interaction among heme oxygenase, nuclear factor-kappaB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52, 910-7.
    30. Ndisang JF, Zhao W & Wang R (2002) Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 40, 315-21.
    31. Teran FJ, Johnson RA, Stevenson BK, Peyton KJ, Jackson KE, Appleton SD, Durante W & Johnson FK (2005) Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 288, R615-22.
    32. Leffler CW, Parfenova H & Jaggar JH (2011) Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol 301, H1-H11.
    33. Marazioti A, Bucci M, Coletta C, Vellecco V, Baskaran P, Szabó C, Cirino G, Marques AR, Guerreiro B, Gonçalves AM, Seixas JD, Beuve A, Romão CC & Papapetropoulos A (2011) Inhibition of nitric oxide-stimulated vasorelaxation by carbon monoxide-releasing molecules. Arterioscler Thromb Vasc Biol 31, 2570-6.
    34. Paranjape SA & Briski KP (2005) Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation. Neuroscience 130, 957-70.
    35. Ishizaka N, Aizawa T, Mori I, Taguchi J, Yazaki Y, Nagai R & Ohno M (2000) Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol 279, H672-8.
    36. Ishizaka N, Aizawa T, Ohno M, Usui Si S, Mori I, Tang SS, Ingelfinger JR, Kimura S & Nagai R (2002) Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension 39, 122-8.
    37. Ishizaka N, Leon HD, Laursen JB, Fukui T, Wilcox JN, Keulenaer GD, Greindling KK & Alexander RW (1997) Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96, 1932-1929.
    38. Datta PK, Dhupar S & Lianos EA (2006) Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis. Nephrol Dial Transplant 21, 51-57.
    39. Thorup C, Jones CL, Gross SS, Moore LC & Goligorsky MS (1999) Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277, F882-9.
    40. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK & Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97, 1916-23.
    41. Johansson ME, Anderson IJ, Alexanderson C, Skott O, Holmang A & Bergstrom G (2008) Hyperinsulinemic rats are normotensive but sensitized to angiotensin II. Am J Regul Integr Comp Physiol 294, R1240-7.
    42. Botros FT, Schwartzman ML, Stier CT, Goodman AL & Abraham NG (2005) Increase in heme oxygenase-1 levels ameliorates renovascular hypertension Kidney Int 68, 45-55.
    43. Quadri S, Prathipati P, Jackson DW & Jackson KE (2013) Augmentation of heme oxygenase promotes acute angiotensin II induced hypertension. Clin Exp Med Sci 1, 21-43.

  • Downloads

  • How to Cite

    Quadri, S., Prathipati, P., Jackson, D., & Jackson, K. (2014). Regulation of heme oxygenase-1 induction during recurrent insulin induced hypoglycemia. International Journal of Medicine, 2(2), 47-52. https://doi.org/10.14419/ijm.v2i2.2902

    Received date: 2014-05-22

    Accepted date: 2014-06-14

    Published date: 2014-06-23